IP Library Granted Patent US 9,068,192
Granted Patent B2
US 9,068,192 · App. 12/695,605 · Granted Jun 30, 2015

Compositions and methods for conversion of aldehydes to alkanes

Inventors: Weiqing Zeng (Okemos, MI); Sheng Yang He (Okemos, MI)
Assignee: Board of Trustees of Michigan State University
C12N15/8247C07K14/415C12N9/0008C12P7/6463C12P7/6481
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 9,068,192
App. No.
12/695,605
Granted
Jun 30, 2015
Kind
B2
Abstract

The invention provides the discovery that SCD2 (Susceptible to Coronatine-Deficient Pst DC3118-2) protein converts aldehydes to alkanes, thereby changing the composition and/or amount of synthesized waxes. The invention additionally provides homologs, orthologs and paralogs of SCD2 protein, and nucleotide sequences encoding these proteins. Also provided are expression vectors, transgenic cells, transgenic plants, transgenic seeds, methods for altering alkane production in cells, methods for identifying the function of a nucleotide sequence in the synthesis of plant surface wax, and methods for identifying plant tissue that has an altered surface wax composition. The invention's compositions and methods are useful for altering the amount and/or composition of wax produced by cells, including plants and seeds, that have been transformed with the invention's sequences.

Claims (5)

1. A transgenic cell comprising a heterologous nucleic acid encoding a polypeptide with a sequence that is at least 95% identical to SEQ ID NO:2, wherein the cell converts 10% more aldehyde to alkane than a cell without the heterologous nucleic acid.

2. The transgenic cell of claim 1 , wherein the cell is a eukaryotic cell.

3. The transgenic cell of claim 1 , wherein the cell is a prokaryotic cell.

4. A transgenic plant comprising a heterologous nucleic acid encoding a polypeptide with a sequence that is at least 95% identical to SEQ ID NO:2, wherein the plant converts 10% more aldehyde to an alkane than a plant that lacks the heterologous nucleic acid.

5. A transgenic plant seed comprising a heterologous nucleic acid encoding a polypeptide with a sequence that is at least 95% identical to SEQ ID NO:2, wherein a plant grown from the seed converts 10% more aldehyde to alkane than a plant without the heterologous nucleic acid.

Assignments (3)
CONFIRMATORY LICENSE Recorded Nov 8, 2013
From: MICHIGAN STATE UNIVERSITY
To: NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT
Reel/Frame 031600/0514 →
CONFIRMATORY LICENSE Recorded Oct 28, 2013
From: MICHIGAN STATE UNIVERSITY
To: NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT
Reel/Frame 031498/0913 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jun 7, 2010
From: ZENG, WEIQING; HE, SHENG YANG
To: BOARD OF TRUSTEES OF MICHIGAN STATE UNIVERSITY
Reel/Frame 024496/0978 →
Continuity (2)
Provisional Application 61147869 · Jan 28, 2009
Related Publication 20100251428A1 · Sep 30, 2010